EZZ Life Science Holdings Ltd (EZZ) — Cash Flow Reinvestment Rate

Latest as of June 2025: 0.02x

EZZ Life Science Holdings Ltd (EZZ) has a Cash Flow Reinvestment Rate of 0.02x as of June 2025, reinvesting AU$48.35K (capex AU$48.35K ) from operating cash flow of AU$2.86 Million. Check cash flow quality index of EZZ Life Science Holdings Ltd to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.02x
(Capex + Investments) / Operating CF

Total Reinvested

AU$48.35K
Capex + Investments

Operating Cash Flow

AU$2.86 Million
AUD

Capital Expenditures

AU$48.35K
AUD

EZZ Life Science Holdings Ltd Cash Flow Reinvestment Rate (2018–2024)

Historical reinvestment intensity for EZZ Life Science Holdings Ltd across 7 annual periods. Explore EZZ operating cash to total liabilities to assess how comfortably operating cash covers total debt obligations.

Annual Cash Flow Reinvestment Rate for EZZ Life Science Holdings Ltd (2018–2024)

Year-by-year capital reinvestment analysis for EZZ Life Science Holdings Ltd. For live market cap and broader valuation context, see EZZ Life Science Holdings Ltd stock valuation.

Year Reinvestment Rate Total Reinvested (AUD) Operating CF Capex YoY Change
2024 0.19x AU$807.81K AU$4.35 Million AU$260.88K ▲ +34.1%
2023 0.14x AU$850.46K AU$6.14 Million AU$409.29K ▲ +173.0%
2022 0.05x AU$203.57K AU$4.01 Million AU$101.78K ▲ +266.0%
2021 0.01x AU$26.35K AU$1.90 Million AU$13.18K ▼ -89.1%
2020 0.13x AU$32.23K AU$253.53K AU$16.12K ▲ +314.7%
2019 0.03x AU$91.20K AU$2.97 Million AU$91.20K ▲ +402.0%
2018 0.01x AU$2.54K AU$416.33K AU$2.54K
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow